Diabetes News Roundup: August 2018

Slideshow

Highlights include obstructive sleep apnea as a factor for T2DM; a test that distinguishes between T1DM and T2DM; and missed opportunities in diabetes prevention.

Related Videos
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Related Content
US FDA logo in Black over a White Background. | Credit: US Food and Drug Administration

FDA Extends Review for TransCon PTH in Hypoparathyroidism to August 2024

May 14th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
HCPLive Endocrinology Month In Review Thumbnail

Endocrinology Month in Review: April 2024

April 30th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Stock imagery of diabetes related items. | Credit: Fotolia

ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin

April 19th 2024
Article
Close up of a scale depicting body weight. | Credit: iStock

Tirzepatide Shows Benefit in Obstructive Sleep Apnea, SURMOUNT-OSA Trial

April 17th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.